Mascual, Romeo D.
HRN: 29-33-08 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/16/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/16/2026
07/22/2026
IV
1.5gms
Q6h
DM FOOT
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes